245 related articles for article (PubMed ID: 24267438)
1. Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.
Mendis S; Chestnov O
Prog Cardiovasc Dis; 2013; 56(3):314-21. PubMed ID: 24267438
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular diseases and diabetes as economic and developmental challenges in Africa.
Kengne AP; June-Rose McHiza Z; Amoah AG; Mbanya JC
Prog Cardiovasc Dis; 2013; 56(3):302-13. PubMed ID: 24267437
[TBL] [Abstract][Full Text] [Related]
3. Challenges for the management of hypertension in low-resource settings.
Mendis S
Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
[TBL] [Abstract][Full Text] [Related]
4. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Breman JG; Alilio MS; Mills A
Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
[TBL] [Abstract][Full Text] [Related]
5. Non-communicable diseases and health systems reform in low-and-middle-income countries.
Robinson HM; Hort K
Pac Health Dialog; 2012 Apr; 18(1):179-90. PubMed ID: 23240355
[TBL] [Abstract][Full Text] [Related]
6. Health promotion and cardiovascular disease prevention in sub-Saharan Africa.
Sampson UK; Amuyunzu-Nyamongo M; Mensah GA
Prog Cardiovasc Dis; 2013; 56(3):344-55. PubMed ID: 24267442
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive strategies for the prevention and control of diabetes and cardiovascular diseases in Africa: future directions.
Muna WF
Prog Cardiovasc Dis; 2013; 56(3):363-6. PubMed ID: 24267444
[TBL] [Abstract][Full Text] [Related]
8. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa.
Gaziano TA
Heart; 2008 Feb; 94(2):140-4. PubMed ID: 18195120
[TBL] [Abstract][Full Text] [Related]
9. Recognizing global burden of cardiovascular disease and related chronic diseases.
Kelly BB; Narula J; Fuster V
Mt Sinai J Med; 2012; 79(6):632-40. PubMed ID: 23239202
[TBL] [Abstract][Full Text] [Related]
10. Design, content and financing of an essential national package of health services.
Bobadilla JL; Cowley P; Musgrove P; Saxenian H
Bull World Health Organ; 1994; 72(4):653-62. PubMed ID: 7923544
[TBL] [Abstract][Full Text] [Related]
11. The global burden of cardiovascular diseases: a challenge to improve.
Mendis S; Chestnov O
Curr Cardiol Rep; 2014 May; 16(5):486. PubMed ID: 24718672
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ortegón M; Lim S; Chisholm D; Mendis S
BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.
Bovet P; Shamlaye C; Gabriel A; Riesen W; Paccaud F
BMC Public Health; 2006 Jan; 6():9. PubMed ID: 16423280
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of interventions to prevent cardiovascular disease in Australia's indigenous population.
Ong KS; Carter R; Vos T; Kelaher M; Anderson I
Heart Lung Circ; 2014 May; 23(5):414-21. PubMed ID: 24252448
[TBL] [Abstract][Full Text] [Related]
15. NCDs in low and middle-income countries - assessing the capacity of health systems to respond to population needs.
Allotey P; Davey T; Reidpath DD
BMC Public Health; 2014; 14 Suppl 2(Suppl 2):S1. PubMed ID: 25082328
[No Abstract] [Full Text] [Related]
16. Economics of diabetes mellitus.
Krein SL; Funnell MM; Piette JD
Nurs Clin North Am; 2006 Dec; 41(4):499-511, v-vi. PubMed ID: 17059971
[TBL] [Abstract][Full Text] [Related]
17. Integrating services involves cost issues.
Blaney CL
Netw Res Triangle Park N C; 1998; 18(2):20-3. PubMed ID: 12293237
[TBL] [Abstract][Full Text] [Related]
18. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
19. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.
Couser WG; Remuzzi G; Mendis S; Tonelli M
Kidney Int; 2011 Dec; 80(12):1258-70. PubMed ID: 21993585
[TBL] [Abstract][Full Text] [Related]
20. Noncommunicable Disease (NCD) strategic plans in low- and lower-middle income Sub-Saharan Africa: framing and policy response.
Boudreaux C; Noble C; Coates MM; Kelley J; Abanda M; Kintu A; McLaughlin A; Marx A; Bukhman G
Glob Health Action; 2020 Dec; 13(1):1805165. PubMed ID: 32873212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
